Saama Technologies offers the Life Science Analytics Cloud (LSAC), an AI-driven clinical data platform. LSAC is used by over 50 pharma and biotech companies on more than 1,500 studies and provides a unified approach to clinical trial data management and analytics. Its pre-trained, AI-embedded smart applications learn complex patterns in clinical data and deliver predictive insights to accelerate the clinical research process across multiple domains and therapeutic areas. The company intends to use the investment to accelerate strategic initiatives, expand go-to-market capabilities, and further invest in AI research and development. Saama is led by founder and CEO Suresh Katta and is based in Campbell, California. Saama Technologies, based in Campbell, Calif., operates the Life Science Analytics Cloud (LSAC), an AI-powered platform that ingests, integrates, curates, and harmonizes clinical trial operational and patient data from proprietary and external sources. LSAC uses a novel deep learning approach to deliver actionable, regulatory-ready insights and, according to the company, significantly compresses clinical program timelines from clinical plan development to submission judgment for a New Drug Application (NDA). Saama intends to use the proceeds of the financing to expand LSAC and to strengthen its ecosystem of pharma and biotech partners, academia, data providers, and CROs. The company plans to build a suite of collective innovations leveraging the LSAC platform to accelerate clinical trials and reduce costs. The new financing brings Saama's total capital raised since 2015 to $75 million. Suresh Katta is Founder and CEO of Saama. Saama combines its Fluid Analytics Engine, packaged Ready Analytics solutions, services and strategic partnerships to help customers quickly uncover and operationalize strategic data assets. The company focuses on delivering industry-specific analytics that drive concept-to-action-to-value within a short performance period. Saama serves Global 2000 clients and lists customers including Actelion, Brocade, Broadcom, Cisco, CSAA Insurance, Delta Dental, Dignity Health, PayPal, Salesforce.com and Unilever. Headquartered in Silicon Valley, the company emphasizes a solutions-based approach that pairs software and services to create immediate customer value. With the new funding, Saama plans to expand its Ready Analytics solutions and increase its Big Data leadership to meet market demand. The announcement frames the investment as the company’s first institutional capital and a minority financing used to accelerate deployment of its analytics offerings.

Total raised

$505M

Funding rounds

3

Latest round

Equity

Latest activity

Oct 2021